SlideShare a Scribd company logo
1 of 70
Download to read offline
Warong Lapanun MD.
Bhumibol Adulyadej Hospital

                6/2/2011
Mr PM: 54-y-o presenting at a non-PCI
 hospital
• 12.00 Myalgia and fatigue
Epigastric fullness for 2 hrs

• 12.30 : Rx Diclofinac IM
• 12 .45 : VF arrest CPR ,DF x 5
• 13.00 : ECG Ac STEMI inferior
wall+ RVMI BP 90/40 mmHg

•Nearest cath lab 40 min away
   Transfer for primary PCI
   Lysis on Site
   Lysis with immediate transfer to cath lab

   Which type of Lytic Rx will be selected?
%
            20


                        n = 29,222
            15
Mortality




                        p < 0.01

            10
                                                                        7.4
                                               5.7
            5                        4.2
                  3.0


            0
                 < 90              91-120    121-150                 > 150
                         Door-to-Balloon Time (minutes)
                                                     McNamara et al. JACC. 2006;47:2180-6.
192, 509 pts at 645 NRMI hospitals




               Pinto et al. Circulation. 2006;114:2019-2025
• 43801 pts STEMI PPCI    •D2B  Mortality( P<0.001)
• ACC registry 2005-2006   • 30 min = 3.0%
• In hospital Mortality    • 60 min = 3.5%
• Median D2B 83 min.       • 90 min = 4.3%
• Overall MR 4.6%          • 120 min = 5.6%
                           • 180 min = 8.4%


                               Rathor SS,et al. BMJ2009:338;1807
Rathor SS,et al. BMJ2009:338;1807
Mortality Reduction(%)
10
                                             Potential outcomes
        E
8                                            A-B : No benefit
                                             A-C : Benefit
6           D     C
                                             B-C : Benefit
                                             E-D : Harm
4

2                      B     A

0                                                                              Hr
            1          3     6                   12                       24
    Time to Rx is Critical   Opening the artery is 1o Goal ( PCI>lysis)

                                                      Gersh BJ et al. JAMA 2005;293:979-986
Infarct size                       Myocardial Edema




       Myocardial Salvage        Microvascular
                                  obstruction




                            Francone M, et al.JACC2009;23:2145
Fribrinolytic Characteristic
                      SK      r-tPA                        TNK




TIMI flow gr 3      ~30%     ~50%                         ~60%




                             Boden et al. JACC 2007,50;10. 923
Risk Factors     Risk Score   ICH(%)
   Age > 75 yr          0-1        0.69
   Black race            2         1.02
                          3         1.63
   Female
                          4         2.49
   Hx of stroke          >5        4.11
   SBP > 160 mmHg
   Wt <65(w),<80(m)
   INR>4
   Use of rt-PA
CAPTIM: 5 Year Survival
Prehospital Thrombolysis vs Primary PCI

                            Prehosp lysis
                                                <2 hrs
 Survival of Proability


                                 PPCI




                                PPCI
                                                >2 hrs
                          Prehosp lysis




                            Bonnefoy, E. et al. Eur Heart J 2009 30:1598-1606
%
Historical             Points                                                                    40
   Age > 75             3                                                                 35.9
         65-74          2                                                                        35

   DM or HT or          1                                                                        30
   Angina                                                                          26.8
Exam.                                                                       23.4                 25

   SBP<100              3                                                                        20
   HR >100              2                                            16.1
   Killip II-IV         2                                                                        15
                                                              12.4
   Wt < 67kg            1                                                                        10
                                                        7.3
Presentation
                                                  4.4                                            5
   Ant. STE or LBBB     1             1.6   2.2
                                0.8
   Time to Rx > 4 hr    1                                                                        0
                                  0     1     2     3     4      5      6      7      8     >8


                                                        Points
                                            Antman et al Circulation 2000;102:2031-7
ST Resolution




Benjamin M. Scirica JACC 2010;55;1403-1415
   Primary PCI
   Rescue PCI
   Facilitated PCI
   Pharmaco-invasive
I IIa IIb III
                with PCI capability should be Rx with p-
A               PCI within 90 min of FMC .
    Modified




                 without PCI capability who cannot be
B               transferred and PCI within 90 min of FMC
    Modified    should be Rx with Lytic Rx within 30 min,
                unless Lytic Rx is contraindicated.



                     FMC: First Medical Contact
    STEMI within 12 h after onset of symptoms
    At centre without PCI facilities with

>1 high risk features:
1.   Cumulative ST-segment elevation of > 15 mm
2.   New onset LBBB
3.   Previous MI
4.   Killip class of 2 or more or
5.   LV ejection fraction of 35% or less.




 Carlo Di Mario, Lancet 371 February 16, 2008
Carlo Di Mario, Lancet 371 February 16, 2008
   Pts with STEMI within 12 hrs after onset of symptoms
   At centers : No PCI capability
   Rx with Tenecteplase (TNK)
   ST-segment elevation of ≥ 2 mm in two anterior leads or
   ST-segment elevation of ≥ 1 mm in two inferior leads and

One high-risk characteristics:
    1.   Systolic BP < 100 mm Hg,
    2.   HR > 100 bpm,
    3.   Killip class II or III,
    4.   ST- depression of ≥ 2 mm in the anterior leads, or
    5.   ST- elevation of ≥ 1 mm in V4R indicative of RV
         involvement.

    Cantor WJ et al. N Engl J Med 2009;360:2705-2718
TRANSFER AMI
                                          High Risk STEMI  12 hrs, 1059 Pts
                                                 TNK + ASA + Clopidogrel +
  Community                                        Heparin or Enoxaparin
  Hospital
                                                       Randomization
  Emergency
  Department
                                   Pharmacoinvasive :                          Standard Strategy:
                                   Urgent  PCI Centre                 Assess chest pain, ST resolution
                                                                        at 60-90 min after randomization




   PCI Centre                                       Failed Reperfusion*             Successful Reperfusion

                     Cath / PCI within 6 hrs             Cath and Rescue                   Elective Cath
                     regardless of reperfusion            PCI  GP IIb/IIIa                      PCI
                              status                          Inhibitor                     > 24 hrs later

* ST segment resolution < 50% & persistent chest pain, or hemodynamic instability
                                                                              Cantor WJ et al. N Engl J Med 2009;360:2705-2718
Kaplan-Meier Curves


Primary Endpoint* at 30 Days             Re-infarction at 6 Months
                   Std Rx
                                                                         Std Rx

                   Early PCI
                                                                        Early PCI




         *Primary endpoint was death, reinfarction, recurrent ischemia,
        new or worsening heart failure, or cardiogenic shock at 30 days
                                           Cantor WJ et al. N Engl J Med 2009;360:2705-2718
Verheugt, NEJM 2009; 360, 26: 2779-2781
Pharmacoinvasive




Facilitated PCI
                     No Class III
   ER physician activate the Cath Lab
   One call activate the cath lab
   Cath lab team ready in 20-30 min
   Prompt data feed back
   Senior management commitment
   Team-based approach
PCI-Center
ผู้ป่วยเจ็บหน้ำอก
 รอบัตร รอแพทย์ตรวจ
   ทำ EKG ใน 10 นำที
      แพทย์เวร ER
      แพทย์เวร Med
    Fellow cardio
ปรึกษำ staff cardio ผ่ำน single
call operator, rtafheart@gmail.com

 ตำมเจ้ำหน้ำที่ Cath Lab

     Time to Lab

        ส่งทำ PCI
Fast Track MI
EKG ด่วนแพทย์ดูใน 10 นำที
 elevation ตำม staff cardio ทันที
 ST
 ST elevation ………………. MD.
 No
ESC GUIDELINES




European Heart Journal (2008) 29, 2909–2945
ESC PCI
Guidelines 2O10
Mr PM: 54-y-o presenting at a non-PCI
 hospital
• 12.00 Myalgia and fatigue
Epigastric fullness for 2 hrs

• 12.30 : Rx Diclofinac IM
• 12 .45 : VF arrest CPR ,DF x 5
• 13.00 : ECG Ac STEMI inferior
wall+ RVMI BP 90/40 mmHg

•Nearest cath lab 30 min away
   Transfer for PPCI
   14.30 Lab
   100% Prox. RCA
   Clot aspiration
   14.50 Balloon
   Stent 4.0x20 mm
   Final TIMI III flow
   Oxygen,NTG, Morphine
   ASA / Clopidrogrel /Prasugrel/Ticangrelor
   Heparin/ LMWH/ Fonda
   GP IIb IIIa antagonist
   Lab
   Echo
   IABP
   CAG / PCI : Early or Late
Benjamin M. Scirica JACC 2010;55;1403-1415
Universal Definition of MI

                               Spontaneous AMI

                                 Secondary AMI

                              Sudden cardiac death


                             Post PCI : 3x 99%URL

                             Post CABG : 5x 99%URL
URL: upper reference limit            Thygesen et al,Circulation November 27, 2007
Thygesen et al,Circulation November 27, 2007
Benjamin M. Scirica JACC 2010;55;1403-1415
Equally
Effective
            Goncalves PA, et al. Eu Heart J 2005;26:865
   Prevalence increased  RFs:
     ▪   Older age,
     ▪   Predominance of females
     ▪   high rate of DM
     ▪   Smoking and obesity
   Use of preventive medications
   Increasing sensitive Troponin Assay



                                   Robert P, et al. Circulation 2009; 54: 1544
NSTE-ACS
  63%
   Plaque rupture: 80%
   Plaque erosion/spasm
   CASPAR study : 448 ACS
    pts
     ~ 25% of ACS: no culprit lesion
     ~ 50% of no culprit
      IC Ach spasm
     CCBs / nitrates : may benefit
     Endothelial function



                                                     Ong P, et al. JACC 2008; 52:523
CASPAR: Coronary Artery Spasm in Patients With ACS
   OCT  Thin-Capped fibroatheromatous ( TCFA)
            Positive remodeling
      Plaque rupture : Rest-onset, Exertion-trigger



                                                  Plaque shoulder

          Lipid core
                                                                Lipid core




             Thin-capped                       Thick-capped

OCT: Optical Coherence Tomography
                                     Tanaka A. et al. Circulation 2008;118;2368
   Everyone should be on anti-plt and anti-coag
   Choose Rx  Consevative vs Invasive
   Choose antithrombotic regimen 
     The strategy selected
     Bleeding risk of patients
   Strategy selected  Pt risk stratification
   Bleeding vs Ischemic risk  Equally
    important
Antman. Circulation 2001;103:2310-4
57
Inf.
epigastric
  artery
89-y-o lady with severe Lt. RAS and TVD
   Assess/document bleeding risk in every pt.
   Avoid crossover : UFH and LMWH
   Proper dose Wt. and renal function
   Use radial access in pts at high risk of
    bleeding
   Stop anticoag after PCI/ indication?
   Selective “downstream” use of GPI
Acute coronary syndrome
Acute coronary syndrome
Acute coronary syndrome
Acute coronary syndrome
Acute coronary syndrome
Acute coronary syndrome
Acute coronary syndrome
Acute coronary syndrome
Acute coronary syndrome

More Related Content

Viewers also liked

Acute coronary syndrome (2)
Acute coronary syndrome (2)Acute coronary syndrome (2)
Acute coronary syndrome (2)fazalsubhan12345
 
Myocardial Infarction Pathogenesis and Treatment
Myocardial Infarction Pathogenesis and TreatmentMyocardial Infarction Pathogenesis and Treatment
Myocardial Infarction Pathogenesis and TreatmentPUDI CHIRANJEEVI
 
ANGINA PECTORIS
ANGINA PECTORISANGINA PECTORIS
ANGINA PECTORISParth Shah
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentationTaher Haddad
 
How to Become a Thought Leader in Your Niche
How to Become a Thought Leader in Your NicheHow to Become a Thought Leader in Your Niche
How to Become a Thought Leader in Your NicheLeslie Samuel
 

Viewers also liked (8)

Acs acute coronary syndrome
Acs acute coronary syndromeAcs acute coronary syndrome
Acs acute coronary syndrome
 
Acute coronary syndrome (2)
Acute coronary syndrome (2)Acute coronary syndrome (2)
Acute coronary syndrome (2)
 
Myocardial Infarction Pathogenesis and Treatment
Myocardial Infarction Pathogenesis and TreatmentMyocardial Infarction Pathogenesis and Treatment
Myocardial Infarction Pathogenesis and Treatment
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
ANGINA PECTORIS
ANGINA PECTORISANGINA PECTORIS
ANGINA PECTORIS
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentation
 
How to Become a Thought Leader in Your Niche
How to Become a Thought Leader in Your NicheHow to Become a Thought Leader in Your Niche
How to Become a Thought Leader in Your Niche
 

Similar to Acute coronary syndrome

Implications of the transfer ami trial for clinical practice
Implications of the transfer ami trial for clinical practiceImplications of the transfer ami trial for clinical practice
Implications of the transfer ami trial for clinical practiceTrimed Media Group
 
Tact quality of life outcomes
Tact quality of life outcomesTact quality of life outcomes
Tact quality of life outcomesMarilyn Mann
 
STEMI – My Approach 2010
STEMI – My Approach 2010STEMI – My Approach 2010
STEMI – My Approach 2010ishakansari
 
Pfizer at Lehman Brothers Global Health Care Conference
Pfizer at Lehman Brothers Global Health Care ConferencePfizer at Lehman Brothers Global Health Care Conference
Pfizer at Lehman Brothers Global Health Care Conferencefinance5
 
Masszi Tamás: Őssejt transzplantáció (Cml_sct_2012)
Masszi Tamás: Őssejt transzplantáció (Cml_sct_2012)Masszi Tamás: Őssejt transzplantáció (Cml_sct_2012)
Masszi Tamás: Őssejt transzplantáció (Cml_sct_2012)VEAB
 
A magdy when 2 pci after mi
A magdy when 2 pci  after miA magdy when 2 pci  after mi
A magdy when 2 pci after miAhmed Magdy
 
Bohomolets septic shock
Bohomolets septic shockBohomolets septic shock
Bohomolets septic shockDr. Rubz
 
Ecmo en el choque cardiogenico desde la puesta en marcha de un programa de ec...
Ecmo en el choque cardiogenico desde la puesta en marcha de un programa de ec...Ecmo en el choque cardiogenico desde la puesta en marcha de un programa de ec...
Ecmo en el choque cardiogenico desde la puesta en marcha de un programa de ec...Clínica Universidad de Navarra
 
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...Sergio Pinski
 
PRESENTACION TROPONINA. Analytical consideration for high sensitivitty tropon...
PRESENTACION TROPONINA. Analytical consideration for high sensitivitty tropon...PRESENTACION TROPONINA. Analytical consideration for high sensitivitty tropon...
PRESENTACION TROPONINA. Analytical consideration for high sensitivitty tropon...manuelgn4
 
STEMI - Cath Lab
STEMI - Cath LabSTEMI - Cath Lab
STEMI - Cath Labishakansari
 
Arterial Lactate Concentration is a major pronostic factor after elective sur...
Arterial Lactate Concentration is a major pronostic factor after elective sur...Arterial Lactate Concentration is a major pronostic factor after elective sur...
Arterial Lactate Concentration is a major pronostic factor after elective sur...Eric Vibert, MD, PhD
 

Similar to Acute coronary syndrome (20)

Implications of the transfer ami trial for clinical practice
Implications of the transfer ami trial for clinical practiceImplications of the transfer ami trial for clinical practice
Implications of the transfer ami trial for clinical practice
 
Tact quality of life outcomes
Tact quality of life outcomesTact quality of life outcomes
Tact quality of life outcomes
 
STEMI – My Approach 2010
STEMI – My Approach 2010STEMI – My Approach 2010
STEMI – My Approach 2010
 
Current Modalities in the Treatment of Lung Cancer
Current Modalities in the Treatment of Lung CancerCurrent Modalities in the Treatment of Lung Cancer
Current Modalities in the Treatment of Lung Cancer
 
Pfizer at Lehman Brothers Global Health Care Conference
Pfizer at Lehman Brothers Global Health Care ConferencePfizer at Lehman Brothers Global Health Care Conference
Pfizer at Lehman Brothers Global Health Care Conference
 
Newest Strategies in the Treatment of CML/CLL
Newest Strategies in the Treatment of CML/CLLNewest Strategies in the Treatment of CML/CLL
Newest Strategies in the Treatment of CML/CLL
 
Masszi Tamás: Őssejt transzplantáció (Cml_sct_2012)
Masszi Tamás: Őssejt transzplantáció (Cml_sct_2012)Masszi Tamás: Őssejt transzplantáció (Cml_sct_2012)
Masszi Tamás: Őssejt transzplantáció (Cml_sct_2012)
 
A magdy when 2 pci after mi
A magdy when 2 pci  after miA magdy when 2 pci  after mi
A magdy when 2 pci after mi
 
Lawrence Hightower
Lawrence HightowerLawrence Hightower
Lawrence Hightower
 
Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...
Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...
Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...
 
Bohomolets septic shock
Bohomolets septic shockBohomolets septic shock
Bohomolets septic shock
 
Ecmo en el choque cardiogenico desde la puesta en marcha de un programa de ec...
Ecmo en el choque cardiogenico desde la puesta en marcha de un programa de ec...Ecmo en el choque cardiogenico desde la puesta en marcha de un programa de ec...
Ecmo en el choque cardiogenico desde la puesta en marcha de un programa de ec...
 
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
Rol actual del cardiodesfibrilador implantable subcutáneo en la prevención de...
 
PRESENTACION TROPONINA. Analytical consideration for high sensitivitty tropon...
PRESENTACION TROPONINA. Analytical consideration for high sensitivitty tropon...PRESENTACION TROPONINA. Analytical consideration for high sensitivitty tropon...
PRESENTACION TROPONINA. Analytical consideration for high sensitivitty tropon...
 
STEMI - Cath Lab
STEMI - Cath LabSTEMI - Cath Lab
STEMI - Cath Lab
 
Jolly S 201111
Jolly S 201111Jolly S 201111
Jolly S 201111
 
Arterial Lactate Concentration is a major pronostic factor after elective sur...
Arterial Lactate Concentration is a major pronostic factor after elective sur...Arterial Lactate Concentration is a major pronostic factor after elective sur...
Arterial Lactate Concentration is a major pronostic factor after elective sur...
 
Primary angioplasty
Primary angioplastyPrimary angioplasty
Primary angioplasty
 
MON 2011 - Slide 22 - W. Weder - Surgery
MON 2011 - Slide 22 - W. Weder - SurgeryMON 2011 - Slide 22 - W. Weder - Surgery
MON 2011 - Slide 22 - W. Weder - Surgery
 
The Treatment of Hodgkin's Disease (part 2)
The Treatment of Hodgkin's Disease (part 2)The Treatment of Hodgkin's Disease (part 2)
The Treatment of Hodgkin's Disease (part 2)
 

More from taem

ประชุมใหญ่สามัญประจำปี วิทยาลัยแพทย์ฉุกเฉินแห่งประเทศไทย 2562-2563
ประชุมใหญ่สามัญประจำปี วิทยาลัยแพทย์ฉุกเฉินแห่งประเทศไทย 2562-2563ประชุมใหญ่สามัญประจำปี วิทยาลัยแพทย์ฉุกเฉินแห่งประเทศไทย 2562-2563
ประชุมใหญ่สามัญประจำปี วิทยาลัยแพทย์ฉุกเฉินแห่งประเทศไทย 2562-2563taem
 
Thai EMS legislation
Thai EMS legislationThai EMS legislation
Thai EMS legislationtaem
 
ACTEP2014 Agenda
ACTEP2014 AgendaACTEP2014 Agenda
ACTEP2014 Agendataem
 
ACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergencyACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergencytaem
 
ACTEP2014: What is simulation
ACTEP2014: What is simulationACTEP2014: What is simulation
ACTEP2014: What is simulationtaem
 
ACTEP2014: Upcoming trend of lung ultrasound
ACTEP2014: Upcoming trend of lung ultrasoundACTEP2014: Upcoming trend of lung ultrasound
ACTEP2014: Upcoming trend of lung ultrasoundtaem
 
ACTEP2014: The routine to research R2R concept your way out of a research dea...
ACTEP2014: The routine to research R2R concept your way out of a research dea...ACTEP2014: The routine to research R2R concept your way out of a research dea...
ACTEP2014: The routine to research R2R concept your way out of a research dea...taem
 
ACTEP2014: Therapeutic hypothermia for ACTEP 2014
ACTEP2014: Therapeutic hypothermia for ACTEP 2014ACTEP2014: Therapeutic hypothermia for ACTEP 2014
ACTEP2014: Therapeutic hypothermia for ACTEP 2014taem
 
ACTEP2014: Sepsis marker in clinical use
ACTEP2014: Sepsis marker in clinical useACTEP2014: Sepsis marker in clinical use
ACTEP2014: Sepsis marker in clinical usetaem
 
ACTEP2014: Symp Experience in STEMI & NSTEMI & UA ACS cases in ED Ramathibodi...
ACTEP2014: Symp Experience in STEMI & NSTEMI & UA ACS cases in ED Ramathibodi...ACTEP2014: Symp Experience in STEMI & NSTEMI & UA ACS cases in ED Ramathibodi...
ACTEP2014: Symp Experience in STEMI & NSTEMI & UA ACS cases in ED Ramathibodi...taem
 
ACTEP2014: Sepsis management has anything change
ACTEP2014: Sepsis management has anything change ACTEP2014: Sepsis management has anything change
ACTEP2014: Sepsis management has anything change taem
 
ACTEP2014: Patient safety & risk management
ACTEP2014: Patient safety & risk managementACTEP2014: Patient safety & risk management
ACTEP2014: Patient safety & risk managementtaem
 
ACTEP2014: How to set up guideline for MCI
ACTEP2014: How to set up guideline for MCIACTEP2014: How to set up guideline for MCI
ACTEP2014: How to set up guideline for MCItaem
 
ACTEP2014: How to maximise resuscitation in trauma 2014
ACTEP2014: How to maximise resuscitation in trauma 2014ACTEP2014: How to maximise resuscitation in trauma 2014
ACTEP2014: How to maximise resuscitation in trauma 2014taem
 
ACTEP2014: Hot zone
ACTEP2014: Hot zoneACTEP2014: Hot zone
ACTEP2014: Hot zonetaem
 
ACTEP2014: Hemodynamic US in critical care
ACTEP2014: Hemodynamic US in critical careACTEP2014: Hemodynamic US in critical care
ACTEP2014: Hemodynamic US in critical caretaem
 
ACTEP2014: Fast track
ACTEP2014: Fast trackACTEP2014: Fast track
ACTEP2014: Fast tracktaem
 
ACTEP2014 ED director
ACTEP2014 ED directorACTEP2014 ED director
ACTEP2014 ED directortaem
 
ACTEP2014: ED design
ACTEP2014: ED designACTEP2014: ED design
ACTEP2014: ED designtaem
 
ACTEP2014: ED accreditation HA JCI TQA
ACTEP2014: ED accreditation HA JCI TQAACTEP2014: ED accreditation HA JCI TQA
ACTEP2014: ED accreditation HA JCI TQAtaem
 

More from taem (20)

ประชุมใหญ่สามัญประจำปี วิทยาลัยแพทย์ฉุกเฉินแห่งประเทศไทย 2562-2563
ประชุมใหญ่สามัญประจำปี วิทยาลัยแพทย์ฉุกเฉินแห่งประเทศไทย 2562-2563ประชุมใหญ่สามัญประจำปี วิทยาลัยแพทย์ฉุกเฉินแห่งประเทศไทย 2562-2563
ประชุมใหญ่สามัญประจำปี วิทยาลัยแพทย์ฉุกเฉินแห่งประเทศไทย 2562-2563
 
Thai EMS legislation
Thai EMS legislationThai EMS legislation
Thai EMS legislation
 
ACTEP2014 Agenda
ACTEP2014 AgendaACTEP2014 Agenda
ACTEP2014 Agenda
 
ACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergencyACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergency
 
ACTEP2014: What is simulation
ACTEP2014: What is simulationACTEP2014: What is simulation
ACTEP2014: What is simulation
 
ACTEP2014: Upcoming trend of lung ultrasound
ACTEP2014: Upcoming trend of lung ultrasoundACTEP2014: Upcoming trend of lung ultrasound
ACTEP2014: Upcoming trend of lung ultrasound
 
ACTEP2014: The routine to research R2R concept your way out of a research dea...
ACTEP2014: The routine to research R2R concept your way out of a research dea...ACTEP2014: The routine to research R2R concept your way out of a research dea...
ACTEP2014: The routine to research R2R concept your way out of a research dea...
 
ACTEP2014: Therapeutic hypothermia for ACTEP 2014
ACTEP2014: Therapeutic hypothermia for ACTEP 2014ACTEP2014: Therapeutic hypothermia for ACTEP 2014
ACTEP2014: Therapeutic hypothermia for ACTEP 2014
 
ACTEP2014: Sepsis marker in clinical use
ACTEP2014: Sepsis marker in clinical useACTEP2014: Sepsis marker in clinical use
ACTEP2014: Sepsis marker in clinical use
 
ACTEP2014: Symp Experience in STEMI & NSTEMI & UA ACS cases in ED Ramathibodi...
ACTEP2014: Symp Experience in STEMI & NSTEMI & UA ACS cases in ED Ramathibodi...ACTEP2014: Symp Experience in STEMI & NSTEMI & UA ACS cases in ED Ramathibodi...
ACTEP2014: Symp Experience in STEMI & NSTEMI & UA ACS cases in ED Ramathibodi...
 
ACTEP2014: Sepsis management has anything change
ACTEP2014: Sepsis management has anything change ACTEP2014: Sepsis management has anything change
ACTEP2014: Sepsis management has anything change
 
ACTEP2014: Patient safety & risk management
ACTEP2014: Patient safety & risk managementACTEP2014: Patient safety & risk management
ACTEP2014: Patient safety & risk management
 
ACTEP2014: How to set up guideline for MCI
ACTEP2014: How to set up guideline for MCIACTEP2014: How to set up guideline for MCI
ACTEP2014: How to set up guideline for MCI
 
ACTEP2014: How to maximise resuscitation in trauma 2014
ACTEP2014: How to maximise resuscitation in trauma 2014ACTEP2014: How to maximise resuscitation in trauma 2014
ACTEP2014: How to maximise resuscitation in trauma 2014
 
ACTEP2014: Hot zone
ACTEP2014: Hot zoneACTEP2014: Hot zone
ACTEP2014: Hot zone
 
ACTEP2014: Hemodynamic US in critical care
ACTEP2014: Hemodynamic US in critical careACTEP2014: Hemodynamic US in critical care
ACTEP2014: Hemodynamic US in critical care
 
ACTEP2014: Fast track
ACTEP2014: Fast trackACTEP2014: Fast track
ACTEP2014: Fast track
 
ACTEP2014 ED director
ACTEP2014 ED directorACTEP2014 ED director
ACTEP2014 ED director
 
ACTEP2014: ED design
ACTEP2014: ED designACTEP2014: ED design
ACTEP2014: ED design
 
ACTEP2014: ED accreditation HA JCI TQA
ACTEP2014: ED accreditation HA JCI TQAACTEP2014: ED accreditation HA JCI TQA
ACTEP2014: ED accreditation HA JCI TQA
 

Recently uploaded

VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and NightVIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Nightpatanjali9823#S07
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examJunhao Koh
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?DrShinyKajal
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
Tissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood BankingTissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood BankingDrShinyKajal
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project
 
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341Sherrylee83
 
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalTreatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalGokuldas Hospital
 
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfniloofarbarzegari76
 
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...Avani bhatt
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxpalsonia139
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Stepdarmandersingh4580
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSachin Sharma
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerSherrylee83
 
HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...
HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...
HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...Ishita Kashyap
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATROKanhu Charan
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsYash Garg
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Anjali Parmar
 

Recently uploaded (20)

VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and NightVIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Tissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood BankingTissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood Banking
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - Subconscious
 
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
Sell pmk powder cas 28578-16-7 from pmk supplier Telegram +85297504341
 
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalTreatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas Hospital
 
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdf
 
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...
HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...
HIFI* ℂall Girls In Thane West Phone 🔝 9920874524 🔝 💃 Me All Time Serviℂe Ava...
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 

Acute coronary syndrome

  • 1. Warong Lapanun MD. Bhumibol Adulyadej Hospital 6/2/2011
  • 2. Mr PM: 54-y-o presenting at a non-PCI hospital • 12.00 Myalgia and fatigue Epigastric fullness for 2 hrs • 12.30 : Rx Diclofinac IM • 12 .45 : VF arrest CPR ,DF x 5 • 13.00 : ECG Ac STEMI inferior wall+ RVMI BP 90/40 mmHg •Nearest cath lab 40 min away
  • 3.
  • 4. Transfer for primary PCI  Lysis on Site  Lysis with immediate transfer to cath lab  Which type of Lytic Rx will be selected?
  • 5.
  • 6. % 20 n = 29,222 15 Mortality p < 0.01 10 7.4 5.7 5 4.2 3.0 0 < 90 91-120 121-150 > 150 Door-to-Balloon Time (minutes) McNamara et al. JACC. 2006;47:2180-6.
  • 7. 192, 509 pts at 645 NRMI hospitals Pinto et al. Circulation. 2006;114:2019-2025
  • 8. • 43801 pts STEMI PPCI •D2B  Mortality( P<0.001) • ACC registry 2005-2006 • 30 min = 3.0% • In hospital Mortality • 60 min = 3.5% • Median D2B 83 min. • 90 min = 4.3% • Overall MR 4.6% • 120 min = 5.6% • 180 min = 8.4% Rathor SS,et al. BMJ2009:338;1807
  • 9. Rathor SS,et al. BMJ2009:338;1807
  • 10. Mortality Reduction(%) 10 Potential outcomes E 8 A-B : No benefit A-C : Benefit 6 D C B-C : Benefit E-D : Harm 4 2 B A 0 Hr 1 3 6 12 24 Time to Rx is Critical Opening the artery is 1o Goal ( PCI>lysis) Gersh BJ et al. JAMA 2005;293:979-986
  • 11. Infarct size Myocardial Edema Myocardial Salvage Microvascular obstruction Francone M, et al.JACC2009;23:2145
  • 12. Fribrinolytic Characteristic SK r-tPA TNK TIMI flow gr 3 ~30% ~50% ~60% Boden et al. JACC 2007,50;10. 923
  • 13. Risk Factors Risk Score ICH(%)  Age > 75 yr 0-1 0.69  Black race 2 1.02 3 1.63  Female 4 2.49  Hx of stroke >5 4.11  SBP > 160 mmHg  Wt <65(w),<80(m)  INR>4  Use of rt-PA
  • 14. CAPTIM: 5 Year Survival Prehospital Thrombolysis vs Primary PCI Prehosp lysis <2 hrs Survival of Proability PPCI PPCI >2 hrs Prehosp lysis Bonnefoy, E. et al. Eur Heart J 2009 30:1598-1606
  • 15. % Historical Points 40 Age > 75 3 35.9 65-74 2 35 DM or HT or 1 30 Angina 26.8 Exam. 23.4 25 SBP<100 3 20 HR >100 2 16.1 Killip II-IV 2 15 12.4 Wt < 67kg 1 10 7.3 Presentation 4.4 5 Ant. STE or LBBB 1 1.6 2.2 0.8 Time to Rx > 4 hr 1 0 0 1 2 3 4 5 6 7 8 >8 Points Antman et al Circulation 2000;102:2031-7
  • 16. ST Resolution Benjamin M. Scirica JACC 2010;55;1403-1415
  • 17. Primary PCI  Rescue PCI  Facilitated PCI  Pharmaco-invasive
  • 18. I IIa IIb III with PCI capability should be Rx with p- A PCI within 90 min of FMC . Modified without PCI capability who cannot be B transferred and PCI within 90 min of FMC Modified should be Rx with Lytic Rx within 30 min, unless Lytic Rx is contraindicated. FMC: First Medical Contact
  • 19. STEMI within 12 h after onset of symptoms  At centre without PCI facilities with >1 high risk features: 1. Cumulative ST-segment elevation of > 15 mm 2. New onset LBBB 3. Previous MI 4. Killip class of 2 or more or 5. LV ejection fraction of 35% or less. Carlo Di Mario, Lancet 371 February 16, 2008
  • 20. Carlo Di Mario, Lancet 371 February 16, 2008
  • 21. Pts with STEMI within 12 hrs after onset of symptoms  At centers : No PCI capability  Rx with Tenecteplase (TNK)  ST-segment elevation of ≥ 2 mm in two anterior leads or  ST-segment elevation of ≥ 1 mm in two inferior leads and One high-risk characteristics: 1. Systolic BP < 100 mm Hg, 2. HR > 100 bpm, 3. Killip class II or III, 4. ST- depression of ≥ 2 mm in the anterior leads, or 5. ST- elevation of ≥ 1 mm in V4R indicative of RV involvement. Cantor WJ et al. N Engl J Med 2009;360:2705-2718
  • 22. TRANSFER AMI High Risk STEMI  12 hrs, 1059 Pts TNK + ASA + Clopidogrel + Community Heparin or Enoxaparin Hospital Randomization Emergency Department Pharmacoinvasive : Standard Strategy: Urgent  PCI Centre Assess chest pain, ST resolution at 60-90 min after randomization PCI Centre Failed Reperfusion* Successful Reperfusion Cath / PCI within 6 hrs Cath and Rescue Elective Cath regardless of reperfusion PCI  GP IIb/IIIa  PCI status Inhibitor > 24 hrs later * ST segment resolution < 50% & persistent chest pain, or hemodynamic instability Cantor WJ et al. N Engl J Med 2009;360:2705-2718
  • 23. Kaplan-Meier Curves Primary Endpoint* at 30 Days Re-infarction at 6 Months Std Rx Std Rx Early PCI Early PCI *Primary endpoint was death, reinfarction, recurrent ischemia, new or worsening heart failure, or cardiogenic shock at 30 days Cantor WJ et al. N Engl J Med 2009;360:2705-2718
  • 24. Verheugt, NEJM 2009; 360, 26: 2779-2781
  • 25.
  • 27. ER physician activate the Cath Lab  One call activate the cath lab  Cath lab team ready in 20-30 min  Prompt data feed back  Senior management commitment  Team-based approach
  • 28. PCI-Center ผู้ป่วยเจ็บหน้ำอก รอบัตร รอแพทย์ตรวจ ทำ EKG ใน 10 นำที แพทย์เวร ER แพทย์เวร Med Fellow cardio ปรึกษำ staff cardio ผ่ำน single call operator, rtafheart@gmail.com ตำมเจ้ำหน้ำที่ Cath Lab Time to Lab ส่งทำ PCI
  • 29. Fast Track MI EKG ด่วนแพทย์ดูใน 10 นำที  elevation ตำม staff cardio ทันที ST  ST elevation ………………. MD. No
  • 30. ESC GUIDELINES European Heart Journal (2008) 29, 2909–2945
  • 32.
  • 33. Mr PM: 54-y-o presenting at a non-PCI hospital • 12.00 Myalgia and fatigue Epigastric fullness for 2 hrs • 12.30 : Rx Diclofinac IM • 12 .45 : VF arrest CPR ,DF x 5 • 13.00 : ECG Ac STEMI inferior wall+ RVMI BP 90/40 mmHg •Nearest cath lab 30 min away
  • 34. Transfer for PPCI  14.30 Lab  100% Prox. RCA  Clot aspiration  14.50 Balloon  Stent 4.0x20 mm  Final TIMI III flow
  • 35.
  • 36. Oxygen,NTG, Morphine  ASA / Clopidrogrel /Prasugrel/Ticangrelor  Heparin/ LMWH/ Fonda  GP IIb IIIa antagonist  Lab  Echo  IABP  CAG / PCI : Early or Late
  • 37.
  • 38. Benjamin M. Scirica JACC 2010;55;1403-1415
  • 39. Universal Definition of MI Spontaneous AMI Secondary AMI Sudden cardiac death Post PCI : 3x 99%URL Post CABG : 5x 99%URL URL: upper reference limit Thygesen et al,Circulation November 27, 2007
  • 40. Thygesen et al,Circulation November 27, 2007
  • 41. Benjamin M. Scirica JACC 2010;55;1403-1415
  • 42.
  • 43. Equally Effective Goncalves PA, et al. Eu Heart J 2005;26:865
  • 44.
  • 45.
  • 46. Prevalence increased  RFs: ▪ Older age, ▪ Predominance of females ▪ high rate of DM ▪ Smoking and obesity  Use of preventive medications  Increasing sensitive Troponin Assay Robert P, et al. Circulation 2009; 54: 1544
  • 48. Plaque rupture: 80%  Plaque erosion/spasm  CASPAR study : 448 ACS pts  ~ 25% of ACS: no culprit lesion  ~ 50% of no culprit IC Ach spasm  CCBs / nitrates : may benefit  Endothelial function Ong P, et al. JACC 2008; 52:523 CASPAR: Coronary Artery Spasm in Patients With ACS
  • 49. OCT  Thin-Capped fibroatheromatous ( TCFA)  Positive remodeling  Plaque rupture : Rest-onset, Exertion-trigger Plaque shoulder Lipid core Lipid core Thin-capped Thick-capped OCT: Optical Coherence Tomography Tanaka A. et al. Circulation 2008;118;2368
  • 50. Everyone should be on anti-plt and anti-coag  Choose Rx  Consevative vs Invasive  Choose antithrombotic regimen   The strategy selected  Bleeding risk of patients  Strategy selected  Pt risk stratification  Bleeding vs Ischemic risk  Equally important
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57. 57
  • 58.
  • 60. 89-y-o lady with severe Lt. RAS and TVD
  • 61. Assess/document bleeding risk in every pt.  Avoid crossover : UFH and LMWH  Proper dose Wt. and renal function  Use radial access in pts at high risk of bleeding  Stop anticoag after PCI/ indication?  Selective “downstream” use of GPI